Skip to main content
. 2020 May 11;2020:5859023. doi: 10.1155/2020/5859023

Figure 3.

Figure 3

Different fecal virome enrichment in the three groups. (a) Linear discriminant analysis effect size (LEfSe) to identify virus that is differentially represented among healthy donors and UC patients before and after treatment. Note: a, healthy controls; b, UC patients before QYSX treatment; c, UC patients after QYSX treatment. (b) STAMP difference analysis used to compare the abundance of species between before and after treatment in UC patients. Note: b, UC patients before QYSX treatment; c, UC patients after QYSX treatment.